Fusion Antibodies PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fusion Antibodies PLC with three other
companies in this sector in UNITED KINGDOM :
Redx Pharma PLC
sales of £5.69 million [US$7.90 million]
Avacta Group Plc
(£3.64 million [US$5.05 million]
Silence Therapeutics Plc
(£5.48 million [US$7.61 million]
of which 100%
was RNA therapeutics).
Fusion Antibodies PLC reported sales of £3.90 million (US$5.41 million)
March of 2020.
increase of 78.5%
versus 2019, when the company's sales were £2.18 million.